Development of newborn and infant vaccines

Related Experiment Video

Updated: May 31, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Guzman Sanchez-Schmitz1, Ofer Levy

  • 1Children's Hospital Boston, Boston, MA 02115, USA. ofer.levy@childrens.harvard.edu

Science Translational Medicine
|July 8, 2011
PubMed

Insights

Developing effective vaccines for infants requires understanding their unique immune responses. Current vaccine development is inconsistent, highlighting the need for age-specific models to ensure safety and efficacy in newborns and infants.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Early-life immunization is critical for global health, reducing infant morbidity and mortality.
  • Current vaccine development for infants relies on empirical methods, leading to inconsistencies.
  • Infant immune responses differ significantly from adults and animal models, complicating prediction.

Purpose of the Study:

  • To emphasize the necessity of understanding age-specific human immune responses.
  • To advocate for the rational design of vaccines tailored for newborns and infants.
  • To highlight the limitations of current models in predicting infant vaccine responses.

Main Methods:

  • This study is a review and conceptual analysis.
  • It synthesizes existing knowledge on infant immunology and vaccine development.
  • It proposes a shift towards age-specific modeling.

Main Results:

  • Infant immune systems exhibit distinct characteristics not mirrored in adults or animal models.
  • Existing vaccine development strategies for early life are often empirical and lack standardization.
  • Predictive models for infant immune responses are currently insufficient.

Conclusions:

  • Rational vaccine design for infants necessitates a deep understanding of their unique immune profiles.
  • Developing accurate models of age-specific human immune responses is vital for creating safe and effective infant vaccines.
  • A paradigm shift towards evidence-based, age-tailored vaccine development is crucial for improving global child health outcomes.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...